Pathophysiology involves heightened TRPV1 receptor sensitivity, neurogenic inflammation, and reduced barrier integrity.
Strip the routine to gentle cleanser, ceramide moisturizer, mineral SPF. Reintroduce actives one at a time at 14-day intervals. Avoid essential oils, fragrance, and physical exfoliants.
If you're targeting sensitivity, this research supports adding centella to your AM/PM routine. Effective concentration range: 60–70% based on this study.
If you're targeting sensitivity, this research supports adding panthenol to your AM/PM routine. Effective concentration range: 60–70% based on this study.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Sensitive skin syndrome involves TRPV1 receptor hypersensitivity, neurogenic inflammation cascade, and stratum corneum dysfunction. Prevalence: 60–70% women, 50–60% men. Distinguish from rosacea, AD, and contact dermatitis. Therapy: minimalist regimen, ceramide-rich emollient, TRPV1-modulating ingredients (4-tert-butylcyclohexanol), avoidance protocol.
Sensitive skin affects 60–70% of women and 50–60% of men. Pathophysiology involves heightened TRPV1 receptor sensitivity, neurogenic inflammation, and reduced barrier integrity. Differentiation from rosacea and atopic dermatitis is clinical. Management centers on minimalist skincare, barrier reinforcement, and avoidance of identified triggers.
Original source →Bakuchiol (BAK), a meroterpene phenol abundant in the plant Psoralea corylifolia, is an emerging cosmeceutical agent with promising anti-aging, anti-inflammatory, and antibacterial properties. The trend for "clean" skincare products and search for anti-aging retinoid alternatives have poised BAK as a "must-have" ingredient in skincare. Our aim was to review the data for the applications of BAK in dermatology.
The efficacy of topical therapies in dermatology is often limited by the barrier function of the stratum corneum, which restricts drug penetration. Iontophoresis is a non-invasive transdermal delivery technique that uses a low-intensity electrical current to enhance the transport of charged and polar molecules across the skin. It has emerged as a strategy to improve local drug bioavailability while minimizing systemic exposure.
Xerosis cutis is characterized by impaired epidermal barrier function, increased transepidermal water loss (TEWL), reduced hydration, and symptoms such as pruritus. To evaluate the efficacy, tolerability, and subjective perception of a topical formulation containing panthenol, niacinamide, and dipotassium glycyrrhizate in improving skin hydration and barrier function in subjects with dry, sensitive skin. In this randomized, intra-individual, split-leg clinical trial, subjects with xerosis applied the test emollient twice daily for 28 days to one pretibial area.
This information is for educational purposes only and is not medical advice. Individual results vary. Consult a qualified dermatologist or healthcare professional for medical concerns. Full disclaimer →